Polyp Histology Prediction by Artificial Intelligence

NCT ID: NCT05545189

Last Updated: 2022-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-31

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We have been developing artificial intelligence based polyp histology prediction (AIPHP) method to classify Narrow Band Imaging(NBI) colonoscopy images to predict the hyperplastic or neoplastic histology of polyps.

We plan to study colonoscopy polyp samples taken by polypectomy from 1200 patients.The documented NBI still images will be analyzed by the AIPHP method and by the NICE classification parallel.Our aim is to analyze the accuracy of AIPHP and NBI classification based histology predictions and also compare the results of the two methods.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

Colonoscopy with polypectomy or early colorectal neoplastic lesions (polyp) is a proven and widely accepted method of reducing colorectal cancer mortality rates.

Predicting histology prior to endoscopic colorectal polyp removal is useful especially for diminutive (1-5mm) and small (6-10mm ) polyps.

Evaluation of colorectal polyps using the narrow-band imaging (NBI) technique and the NBI International Colorectal Endoscopic (NICE) classification are useful to predict the histology during endoscopy.However, NBI and magnification based polyp histology prediction needs training and endoscopic experience. Morever , the final and objective diagnosis still requires histology.

Therefore,we have been developing arteficial intelligence-based polyp histology prediction (AIPHP) software to automatically evaluate the magnified NBI colonoscopy images aiming the histology prediction of polyps.

Materials and methods:

We plan to examine 1200 colorectal polyps obtained from patients. Polyps will be removed by traditional polypectomy or with mucosectomy.Endoscopic procedures and histological examinations performed at the participation hospitals. Colonoscopy will be performed with Olympus EXERA III CFHQ190I (Olympus ,Tokyo,Japan) high reolution NBI colonoscopes providing 65x optical magnification. Colorectal polyps will be detected first by high definition colonoscopy then by NBI at the optical maximum magnification (65x). All studied polyps will be photo-documented. The stored NBI photos were anelyzed by the NICE classification and AIPHP parallel system.

Histological examination methods:

We use WHO classification of colorectal polyps. The two -class classification will considere hyperplastic or neoplastic ((SSLs,tubular or villous adenomas, and invasive adenocarcinomas).

AIPHP software systtem:

The AIPHP software is based on the categorization of the vascular pattern and color of the polyps.The main steps of AIPHP software development will be the following: 1) feature vector calculation 2) training of classifier module, and 3) AIPHP classifier testing. Five features will be used by our AIPHP software.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Polyp

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

colonoscopy group1

Polypectomy, histological examination, NICE classification and AIPHP analyzis will be performed 200 patients.

colonoscopy,polypectomy

Intervention Type DIAGNOSTIC_TEST

polyp removal during colonoscopy

colonoscopy group 2

Polypectomy, histological examination, NICE classification and AIPHP analyzis will be performed 200 patients

colonoscopy,polypectomy

Intervention Type DIAGNOSTIC_TEST

polyp removal during colonoscopy

colonoscopy group 3

Polypectomy, histological examination, NICE classification and AIPHP analyzis will be performed 200 patients

colonoscopy,polypectomy

Intervention Type DIAGNOSTIC_TEST

polyp removal during colonoscopy

colonoscopy group 4

Polypectomy, histological examination, NICE classification and AIPHP analyzis will be performed 200 patients

colonoscopy,polypectomy

Intervention Type DIAGNOSTIC_TEST

polyp removal during colonoscopy

colonoscopy group 5

Polypectomy, histological examination, NICE classification and AIPHP analyzis will be performed 200 patients

colonoscopy,polypectomy

Intervention Type DIAGNOSTIC_TEST

polyp removal during colonoscopy

colonoscopy group 6

Polypectomy, histological examination, NICE classification and AIPHP analyzis will be performed 200 patients

colonoscopy,polypectomy

Intervention Type DIAGNOSTIC_TEST

polyp removal during colonoscopy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

colonoscopy,polypectomy

polyp removal during colonoscopy

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* colorectal polyps removed by polypectomy

Exclusion Criteria

* colorectal polyps with IBD
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Petz Aladar County Teaching Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PetzACTH2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.